CIK 0001464521 · <br>Emerging growth company
Heartflow, Inc.
Sign in to watch- Ticker
- HTFL
- Exchange
- Nasdaq
- Industry
- Surgical & Medical Instruments & Apparatus
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 260506743
- Phone
- 650-241-1221
- Business address
- 135 MAIN STREET, SUITE 1000, SAN FRANCISCO, CA, 94105
- Former names
- Cardiovascular Simulation, Inc.
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $16,602,722
- in 13 filings, $16.6M under 10b5-1 plans
Net −$16,602,722. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2026-09-17 | Verghese Vikram Chief Financial Officer | Sale 10b5-1 | −7,579 | $50.11 | $380K | 171,949 |
| 2026-09-15 | Verghese Vikram Chief Financial Officer | Sale 10b5-1 | −668 | $50.01 | $33K | 179,528 |
| 2026-09-14 | Verghese Vikram Chief Financial Officer | Sale 10b5-1 | −4,593 | $50.24 | $231K | 180,196 |
| 2026-09-11 | Verghese Vikram Chief Financial Officer | Sale 10b5-1 | −29,714 | $50.06 | $1.5M | 184,789 |
| 2026-09-11 | Farquhar John C.M. Chief Executive Officer | Sale 10b5-1 | −3,890 | $50.00 | $195K | 321,914 |
| 2026-09-10 | Farquhar John C.M. Chief Executive Officer | Sale 10b5-1 | −35,010 | $46.42 | $1.6M | 325,804 |
| 2026-09-08 | Jones Marie L. Chief Accounting Officer | Grant or award | +795 | $19.70 | $16K | 32,971 |
| 2026-09-08 | Verghese Vikram Chief Financial Officer | Sale 10b5-1 | −6,640 | $50.03 | $332K | 214,503 |
| 2026-09-03 | Verghese Vikram Chief Financial Officer | Sale 10b5-1 | −27,540 | $49.69 | $1.4M | 221,143 |
| 2026-09-02 | Verghese Vikram Chief Financial Officer | Sale 10b5-1 | −5,876 | $50.60 | $297K | 248,683 |
| 2026-08-21 | Farquhar John C.M. Chief Executive Officer | Sale 10b5-1 | −27,230 | $50.00 | $1.4M | 360,814 |
| 2026-08-18 | Farquhar John C.M. Chief Executive Officer | Sale 10b5-1 | −32,676 | $45.00 | $1.5M | 388,044 |
| 2026-08-17 | Rogers Campbell Chief Medical Officer | Option exercise 10b5-1 | +9,219 | $19.00 | $175K | 95,678 |
| 2026-08-17 | Rogers Campbell Chief Medical Officer | Sale 10b5-1 | −9,219 | $41.23 | $380K | 86,459 |
| 2026-08-17 | Rogers Campbell Chief Medical Officer | Option exercise · Stock Options 10b5-1 | −9,219 | 82,972 | ||
| 2026-08-14 | Farquhar John C.M. Chief Executive Officer | Sale 10b5-1 | −15,560 | $39.06 | $608K | 420,720 |
| 2026-08-10 | Farquhar John C.M. Chief Executive Officer | Sale 10b5-1 | −22,562 | $28.31 | $639K | 436,280 |
| 2026-08-07 | Jones Marie L. Chief Accounting Officer | Shares withheld for taxes | −82 | $28.82 | $2K | 32,176 |
| 2026-08-07 | Verghese Vikram Chief Financial Officer | Shares withheld for taxes | −473 | $28.82 | $14K | 254,559 |
| 2026-08-07 | Rogers Campbell Chief Medical Officer | Shares withheld for taxes | −637 | $28.82 | $18K | 86,459 |
Page 2 of 12 · 224 trades